co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis.

• 收藏
• 分享

专利权人:

LEVOLTA PHARMACEUTICALS; INC.

发明人:

DESAI, KETAN

申请号：

BR112015021503

公开号：

BR112015021503A2

申请日:

2014.03.07

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/